|
Technology | Biomarkers and/or pathway | Source type | References |
|
Epigenetics | HMT Set7 overexpression and NF-κB p65 activation | Human aortic endothelial cells (HAECs) exposed to high glucose and aortas of diabetic mice | [82] |
Hyperacetylation of histone H3K9/K14 | Human aortic endothelial cells (HAECs) in high glucose or low glucose | [57] |
SIRT1 overexpression | Endothelial cells (ECs) and tissues from diabetic male C57BL/6 mice | [85, 86] |
Angiogenesis-associated miRNAs (angioMiRs), inflammation-associated miRNAs (inflammaMiRs), and senescence-associated miRNAs (seneMiRs) | Endothelial cells (ECs); human dermal microvascular endothelial cells (HMVECs); human umbilical vein endothelial cells (HUVECs); vascular smooth muscle cells (VSMCs) | [58, 87] |
miR-155 | Endothelial cells (ECs); vascular smooth muscle cells (VSMCs); female Apoe–/– mice | [88, 89] |
miR-126 | Plasma of sepsis patients and healthy controls; RAW264.7 macrophages; human umbilical vein endothelial cells (HUVECs); human promyelocytic cell line HL-60; endothelial cells derived from mouse embryonic stem (ES) cells; knockdown of miR-126 in zebrafish | [90–92] |
miR-146a | Human umbilical vein endothelial cells (HUVECs) | [93] |
miR-200c | Endothelial cells (ECs); human umbilical vein endothelial cells (HUVECs); C2C12 myoblasts; primary normal human fibroblasts | [94, 95] |
IncRNAs | Human umbilical vein endothelial cells (HUVECs) cultured under high or normal glucose conditions | [97] |
IncRNA-MEG3 | Retinas of STZ-induced diabetic mice; endothelial cells (ECs) | [98] |
|
Metabolomics | Low plasma histidine, high butenoylcarnitine Low hexose, glutamine, and tyrosine | Urine and plasma of T2D patients | [109] |
Alterations of carbonyl stress, carbohydrate metabolism, amino acid metabolism pathways, in particular vitamin B6, propanoate, and butanoate metabolism | Mouse aortic cells | [110] |
Alanine, proline, glycine, serine, and glutamine alterations | Human aortic endothelial cells (HAECs) exposed to acute and chronic hyperglycemia | [111] |
Glycosphingolipid pathway | Plasma of hyperglycemic mice and glucosamine-supplemented mice | [112] |
Gamma-glutamyl cycle impairment and increased methylglyoxal | Human umbilical vein endothelial cells (HUVECs) | [114] |
|